The convergence of stress and sex on Abeta and tau metabolism and pathology

压力和性对 Abeta 和 tau 代谢及病理学的影响

基本信息

  • 批准号:
    10734280
  • 负责人:
  • 金额:
    $ 213.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Psychological stress is one of the largest environmental risk factors for Alzheimer’s disease (AD). Women are more prone to stress and are at higher risk of AD than men. Our preliminary data demonstrate a sex- dependent effect of stress on both Aβ and tau. In two distinct models of acute stress, restraint stress and predatory olfactory stress, only females have a rapid and prolonged increase in brain interstitial fluid (ISF) Aβ levels in the hippocampus, whereas Aβ in males does not change. The increase in females is blocked by inhibiting the CRF receptor (CRF-R). Interestingly, CRF-Rs signal differently in females and males. During stress in females, CRF-Rs normally activate PKA/ERK whereas in males CRF-Rs are withdrawn from the plasma membrane by β-arrestin, so there is significantly less CRF signaling in males. Consistent with this mechanism, our preliminary data demonstrates β-arrestin1 knockout males have restored CRF-Rs on the cell surface, and when stressed ISF Aβ levels increase nearly identically to females. Our data also demonstrate a similar sexual dimorphic response to stress for tau. In response to stress, ISF tau levels increase in both males and females, but females have a 4-fold greater increase than males. The literature demonstrates that corticosterone, a main stress protein throughout the body, can increase tau levels. We propose that the disparate tau responses in each sex are primarily driven by two mechanisms: 1) differential CRF-R signaling that drives the difference between the sexes, similar to A and 2) a common mechanism in both sexes that is driven by corticosterone to increase tau levels similarly in males and females. While previous studies have implicated CRF and β-arrestin in AD, these will be some of the first studies studying these pathways in AD in the setting of stress. We hypothesize that stress causes sex-dependent increases on Aβ and tau that are mediated by CRF-R/β-arrestin signaling, as well as sex-independent effects on tau driven by corticosterone. We propose to determine the signaling pathways that are activated by acute stress in males and females to regulate Aβ and tau levels differently. We will also chronically stress mice that have altered CRF or corticosterone (cort) signaling or lack β-arrestin expression to determine effects on behavior and pathology. Our premise is that determining the cellular pathways that differ between the sexes could identify risks of developing AD and lead to therapeutics to specifically modulate the stress response in AD based on sex.
心理应激是阿尔茨海默病(AD)最大的环境危险因素之一。女人 她们比男性更容易受到压力,患上阿尔茨海默病的风险更高。我们的初步数据显示了性行为- 应激对Aβ和tau的依赖效应。在两种不同的急性应激模式中,束缚应激和 掠夺性嗅觉应激,只有女性脑间质液(ISF)Aβ快速而持久地增加 在海马体中的水平,而男性的Aβ没有改变。女性人数的增加受到以下因素的阻碍 抑制CRF受体(CRF-R)。有趣的是,CRF受体在女性和男性身上的信号不同。在.期间 在女性,CRF-R通常激活PKA/ERK,而在男性,CRF-R从 质膜上受β-arrestin调节,所以雄性体内CRF信号明显较少。与此一致 机制,我们的初步数据表明β-arrestin1基因敲除的雄性已经恢复了细胞上的CRF-R 当应激时,ISFAβ水平的增加与雌性几乎相同。我们的数据还表明, Tau对压力的性二型性反应类似。作为对压力的反应,两个男性的ISF tau水平都会增加 和女性,但女性的增幅是男性的4倍。文献表明, 皮质酮是人体内的一种主要应激蛋白,可以增加tau的水平。我们建议, 不同性别的tau反应主要由两种机制驱动:1)不同的CRF-R信号 这导致了性别之间的差异,类似于A和2)两性之间的一种共同机制,即 在皮质酮的推动下,男性和女性的tau水平都有类似的提高。虽然之前的研究已经 在AD中涉及CRF和β-arrestin,这些将是在AD中研究这些途径的第一批研究 压力的设定。 我们假设压力引起性别依赖性的Aβ和tau的增加,这种增加是由 CRF-R/β-arrestin信号转导,以及皮质酮对tau的非性别影响。我们 建议确定男性和女性在急性应激中激活的信号通路 对A、β和tau水平进行不同的调控。我们还将对CRF或CRF改变的小鼠造成慢性压力 皮质酮(CORT)信号或缺乏β-arrestin的表达,以确定对行为和病理的影响。 我们的前提是,确定不同性别之间的细胞通路可以识别出 发展阿尔茨海默病,并导致基于性别的治疗方法,专门调节阿尔茨海默病的应激反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John R Cirrito其他文献

John R Cirrito的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John R Cirrito', 18)}}的其他基金

Nanobody-based electrochemical biosensor for real-time detection of aerosolized SARS-CoV2
基于纳米抗体的电化学生物传感器,用于实时检测雾化的 SARS-CoV2
  • 批准号:
    10656047
  • 财政年份:
    2022
  • 资助金额:
    $ 213.31万
  • 项目类别:
Nanobody-Based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2
基于纳米抗体的电化学生物传感器,用于实时检测气溶胶 SARS-CoV2
  • 批准号:
    10264330
  • 财政年份:
    2020
  • 资助金额:
    $ 213.31万
  • 项目类别:
Nanobody-Based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2
基于纳米抗体的电化学生物传感器,用于实时检测气溶胶 SARS-CoV2
  • 批准号:
    10320998
  • 财政年份:
    2020
  • 资助金额:
    $ 213.31万
  • 项目类别:
Effects of ApoE-enhancing Compounds on Alzheimers Disease Phenotypes In Vivo
ApoE 增强化合物对体内阿尔茨海默病表型的影响
  • 批准号:
    9752688
  • 财政年份:
    2018
  • 资助金额:
    $ 213.31万
  • 项目类别:
TEMPORAL RELATIONSHIP BETWEEN SYNAPTIC ACTIVITY AND ABETA AGGREGATION
突触活动与 ABETA 聚合之间的时间关系
  • 批准号:
    8699656
  • 财政年份:
    2013
  • 资助金额:
    $ 213.31万
  • 项目类别:
TEMPORAL RELATIONSHIP BETWEEN SYNAPTIC ACTIVITY AND ABETA AGGREGATION
突触活动与 ABETA 聚合之间的时间关系
  • 批准号:
    8566773
  • 财政年份:
    2013
  • 资助金额:
    $ 213.31万
  • 项目类别:
SYNAPTIC REGULATION OF ERK-MEDIATED AMYLOID-BETA METABOLISM
ERK 介导的淀粉样蛋白代谢的突触调节
  • 批准号:
    8517548
  • 财政年份:
    2012
  • 资助金额:
    $ 213.31万
  • 项目类别:
SYNAPTIC REGULATION OF ERK-MEDIATED AMYLOID-BETA METABOLISM
ERK 介导的淀粉样蛋白代谢的突触调节
  • 批准号:
    9064726
  • 财政年份:
    2012
  • 资助金额:
    $ 213.31万
  • 项目类别:
SYNAPTIC REGULATION OF ERK-MEDIATED AMYLOID-BETA METABOLISM
ERK 介导的淀粉样蛋白代谢的突触调节
  • 批准号:
    8342633
  • 财政年份:
    2012
  • 资助金额:
    $ 213.31万
  • 项目类别:
SYNAPTIC REGULATION OF ERK-MEDIATED AMYLOID-BETA METABOLISM
ERK 介导的淀粉样蛋白代谢的突触调节
  • 批准号:
    8661672
  • 财政年份:
    2012
  • 资助金额:
    $ 213.31万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 213.31万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 213.31万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 213.31万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 213.31万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 213.31万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 213.31万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 213.31万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 213.31万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 213.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 213.31万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了